These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 35719786)
1. Efficacy of Radioiodine Therapy in Patients With Primary Hyperthyroidism: An Institutional Review From Pakistan. Alvi AM; Azmat U; Shafiq W; Ali Rasheed AH; Siddiqi AI; Khan S; Ashfaq S; Irfan H; Bashir H; Abu Bakar M; Asghar K Cureus; 2022 May; 14(5):e24992. PubMed ID: 35719786 [TBL] [Abstract][Full Text] [Related]
4. Use of a dosimetry-based RAI protocol for treatment of benign hyperthyroidism optimises response while minimising exposure to ionising radiation. Miller C; Al-Jabri A; O'Murchada L; Mustafa M; Cooke J; Phelan N; Healy ML Clin Endocrinol (Oxf); 2024 Jun; 100(6):585-592. PubMed ID: 38567706 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of radioiodine (131-I) as definitive therapy in patients with autoimmune and non-autoimmune hyperthyroidism. Tarantini B; Ciuoli C; Di Cairano G; Guarino E; Mazzucato P; Montanaro A; Burroni L; Vattimo AG; Pacini F J Endocrinol Invest; 2006; 29(7):594-8. PubMed ID: 16957406 [TBL] [Abstract][Full Text] [Related]
6. Long-term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity. Roque C; Santos FS; Pilli T; Dalmazio G; Castagna MG; Pacini F J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32320467 [TBL] [Abstract][Full Text] [Related]
7. Cure Rates After a Single Dose of Radioactive Iodine to Treat Hyperthyroidism: The Fixed-Dose Regimen. Madu NM; Skinner C; Oyibo SO Cureus; 2022 Aug; 14(8):e28316. PubMed ID: 36039121 [TBL] [Abstract][Full Text] [Related]
8. The feasibility of low-dose oral lithium therapy and its effect on thyroidal radioiodine uptake, retention, and hormonal parameters in various subcategories of hyperthyroid patients: a pilot study. Chouhan A; Abhyankar A; Basu S Nucl Med Commun; 2016 Jan; 37(1):74-8. PubMed ID: 26465804 [TBL] [Abstract][Full Text] [Related]
9. Long-term outcome and prognostic factors of single-dose Radioiodine Therapy in patients with Graves' disease. Yang YT; Chen JF; Tung SC; Kuo MC; Weng SW; Chou CK; Shen FC; Chang CM; Tsai CJ; Taso CF; Wang PW J Formos Med Assoc; 2020 May; 119(5):925-932. PubMed ID: 32057544 [TBL] [Abstract][Full Text] [Related]
10. Predictive value of pyramidal lobe, percentage thyroid uptake and age for ablation outcome after 15 mCi fixed dose of radioiodine-131 in Graves' disease. Zaman MU; Fatima N; Zaman U; Sajjad Z; Zaman A; Tahseen R Indian J Nucl Med; 2015; 30(4):309-13. PubMed ID: 26430313 [TBL] [Abstract][Full Text] [Related]
11. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease. Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440 [TBL] [Abstract][Full Text] [Related]
12. Predictors of euthyreosis in hyperthyroid patients treated with radioiodine Stachura A; Gryn T; Kałuża B; Budlewski T; Franek E BMC Endocr Disord; 2020 Jun; 20(1):77. PubMed ID: 32487052 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease. Martin NM; Patel M; Nijher GM; Misra S; Murphy E; Meeran K Clin Endocrinol (Oxf); 2012 Oct; 77(4):621-7. PubMed ID: 22443227 [TBL] [Abstract][Full Text] [Related]
14. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome. Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of radioactive iodine treatment of graves' hyperthyroidism using a single calculated Wong KK; Shulkin BL; Gross MD; Avram AM Clin Diabetes Endocrinol; 2018; 4():20. PubMed ID: 30505461 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Long-Term Methimazole versus Radioactive Iodine in the Treatment of Toxic Multinodular Goiter. Azizi F; Saadat N; Takyar MA; Abdi H; Mehran L; Amouzegar A Endocrinol Metab (Seoul); 2022 Dec; 37(6):861-869. PubMed ID: 36415961 [TBL] [Abstract][Full Text] [Related]
17. Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication. Ghadban WK; Zirie MA; Al-Khateeb DA; Jayyousi AA; Mobayedh HM; El-Aloosy AS Saudi Med J; 2003 Apr; 24(4):347-51. PubMed ID: 12754531 [TBL] [Abstract][Full Text] [Related]
18. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism. Franklyn JA; Daykin J; Holder R; Sheppard MC QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Fixed Dose Radioactive Iodine (RAI) for the Treatment of Hyperthyroidism: Experience of a Teaching Hospital in South West Nigeria. Enyi Ejeh M J; Omotayo Ogunjobi K; Enyi Ejeh J; Solomon Adedapo K; F Eniojukan J Mol Imaging Radionucl Ther; 2013 Aug; 22(2):36-41. PubMed ID: 24003395 [TBL] [Abstract][Full Text] [Related]
20. Meta-Analysis of Randomized Controlled Trials Comparing the Efficacy of Radioactive Iodine Monotherapy versus Radioactive Iodine Therapy and Adjunctive Lithium for the Treatment of Hyperthyroidism. Ahmed FW; Kirresh OZ; Majeed MS; Iftikhar M; Sajid MS Endocr Res; 2021 Nov; 46(4):160-169. PubMed ID: 34028325 [No Abstract] [Full Text] [Related] [Next] [New Search]